Effect of food additive E171 (titanium dioxide) on the development of colorectal cancer, an early biomarkers research. - E171 and colon cancer

niversitair Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•Healthey volonteers with a Body Mass Index (BMI) between 18-27, male or femelle
•and between 18-70 years old

•- Alcohol abuse up to 6 months before participation in this research, i.e. more
•than 4 drinks on any single day and more than 14 drinks per week for men and
•more than 3 drinks on any single day and more than 7 drinks per week for women
•- Current presence of any diseases related to the gastrointestinal tract,
•kidney, liver, heart or lungs
•- Current presence of symptoms related to diseases of the gastrointestinal
•tract, i.e. vomiting, diarrhoea or constipation, and altered stool, such as
•blood in stool
•- Current presence of diseases related to the endocrine or metabolic system
•- Current presence of anaemia
•- HIV infection or hepatitis
•- Use of antibiotics and other prescribed medication and painkillers over the
•last 3 months (exception: paracetamol and anti-contraceptive)
•- Current smokers
•- Vegetarians
•- Pregnant women
•- Participants of other intervention studies during this intervention period.
•- Participants who use anticoagulant medicine

发起方

niversitair Medisch Centrum